Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs DR. REDDYS LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA DR. REDDYS LAB AUROBINDO PHARMA/
DR. REDDYS LAB
 
P/E (TTM) x 23.0 19.7 116.6% View Chart
P/BV x 2.4 4.4 53.6% View Chart
Dividend Yield % 0.3 0.6 42.4%  

Financials

 AUROBINDO PHARMA   DR. REDDYS LAB
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-23
DR. REDDYS LAB
Mar-23
AUROBINDO PHARMA/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs7154,656 15.3%   
Low Rs3973,788 10.5%   
Sales per share (Unadj.) Rs424.21,481.4 28.6%  
Earnings per share (Unadj.) Rs32.9270.7 12.2%  
Cash flow per share (Unadj.) Rs54.1345.7 15.7%  
Dividends per share (Unadj.) Rs3.0040.00 7.5%  
Avg Dividend yield %0.50.9 57.0%  
Book value per share (Unadj.) Rs458.11,389.6 33.0%  
Shares outstanding (eoy) m585.94166.53 351.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.32.8 46.0%   
Avg P/E ratio x16.915.6 108.3%  
P/CF ratio (eoy) x10.312.2 84.1%  
Price / Book Value ratio x1.23.0 39.9%  
Dividend payout %9.114.8 61.7%   
Avg Mkt Cap Rs m325,753703,039 46.3%   
No. of employees `000NANA-   
Total wages/salary Rs m35,22346,466 75.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m248,554246,697 100.8%  
Other income Rs m2,90610,555 27.5%   
Total revenues Rs m251,460257,252 97.7%   
Gross profit Rs m37,07063,860 58.0%  
Depreciation Rs m12,44612,502 99.6%   
Interest Rs m1,4051,428 98.4%   
Profit before tax Rs m26,12560,485 43.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6,84915,412 44.4%   
Profit after tax Rs m19,27745,073 42.8%  
Gross profit margin %14.925.9 57.6%  
Effective tax rate %26.225.5 102.9%   
Net profit margin %7.818.3 42.4%  
BALANCE SHEET DATA
Current assets Rs m214,599203,161 105.6%   
Current liabilities Rs m114,93885,721 134.1%   
Net working cap to sales %40.147.6 84.2%  
Current ratio x1.92.4 78.8%  
Inventory Days Days2179 26.0%  
Debtors Days Days66107 61.2%  
Net fixed assets Rs m176,668112,638 156.8%   
Share capital Rs m586833 70.3%   
"Free" reserves Rs m267,813230,571 116.2%   
Net worth Rs m268,399231,404 116.0%   
Long term debt Rs m6,1901,278 484.3%   
Total assets Rs m392,125315,799 124.2%  
Interest coverage x19.643.4 45.2%   
Debt to equity ratio x00 417.6%  
Sales to assets ratio x0.60.8 81.1%   
Return on assets %5.314.7 35.8%  
Return on equity %7.219.5 36.9%  
Return on capital %10.026.6 37.7%  
Exports to sales %33.752.2 64.5%   
Imports to sales %15.316.8 91.1%   
Exports (fob) Rs m83,703128,803 65.0%   
Imports (cif) Rs m38,06041,484 91.7%   
Fx inflow Rs m85,483128,803 66.4%   
Fx outflow Rs m41,44741,484 99.9%   
Net fx Rs m44,03687,319 50.4%   
CASH FLOW
From Operations Rs m23,86858,875 40.5%  
From Investments Rs m-39,778-41,373 96.1%  
From Financial Activity Rs m18,144-26,861 -67.5%  
Net Cashflow Rs m2,298-9,073 -25.3%  

Share Holding

Indian Promoters % 48.8 26.7 183.0%  
Foreign collaborators % 3.1 0.0 -  
Indian inst/Mut Fund % 41.3 47.3 87.4%  
FIIs % 20.7 28.6 72.4%  
ADR/GDR % 0.0 15.3 -  
Free float % 48.2 58.0 83.0%  
Shareholders   241,944 257,794 93.9%  
Pledged promoter(s) holding % 20.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Aurobindo Pharma vs Dr. Reddys

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Aurobindo Pharma vs Dr. Reddys Share Price Performance

Period Aurobindo Pharma Dr. Reddys S&P BSE HEALTHCARE
1-Day 1.82% 1.78% 1.18%
1-Month 5.96% -4.23% -0.75%
1-Year 113.07% 35.93% 61.82%
3-Year CAGR 7.78% 10.85% 18.16%
5-Year CAGR 7.18% 17.77% 19.79%

* Compound Annual Growth Rate

Here are more details on the Aurobindo Pharma share price and the Dr. Reddys share price.

Moving on to shareholding structures...

The promoters of Aurobindo Pharma hold a 51.8% stake in the company. In case of Dr. Reddys the stake stands at 26.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Aurobindo Pharma and the shareholding pattern of Dr. Reddys.

Finally, a word on dividends...

In the most recent financial year, Aurobindo Pharma paid a dividend of Rs 3.0 per share. This amounted to a Dividend Payout ratio of 9.1%.

Dr. Reddys paid Rs 40.0, and its dividend payout ratio stood at 14.8%.

You may visit here to review the dividend history of Aurobindo Pharma, and the dividend history of Dr. Reddys.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.